论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
白蛋白结合型紫杉醇治疗复发性艾滋病相关卡波西肉瘤 - 病例报告
Received 10 January 2024
Accepted for publication 23 March 2024
Published 11 April 2024 Volume 2024:17 Pages 1431—1437
DOI https://doi.org/10.2147/IDR.S456286
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Sandip Patil
Introduction: Kaposi sarcoma (KS) incidence has decreased since the initiation of combination antiretroviral therapy (cART), but it remains the most common cancer in people with HIV/AIDS (PWHA). PWHA with advanced immunosuppression who initiate antiretroviral therapy are susceptible to the occurrence of an immune reconstitution inflammatory syndrome (IRIS).
Case Presentation: This report covers the case of a 25-year-old male with AIDS-related KS who relapsed after Liposomal Doxorubicin, but recovered well after administration of nab-paclitaxel (Nab-PTX).
Conclusion: This is a rare case in choosing Nab-PTX to treat relapsed AIDS-KS and get good feedback. We report the case to provide a possible solution to treat AIDS-KS.
Keywords: Kaposi sarcoma, nab-paclitaxel, HIV, case report